QSS
DNLI icon

Quantitative Systematic Strategies’s Denali Therapeutics DNLI Stock Holding History

Quantitative Systematic Strategies’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,301
Closed -$337K – 109
2021
Q2 		$337K Sell
4,301
-6,699
-61% -$414K 0.12% 313
2021
Q1 		$628K Buy
11,000
+7,969
+263% +$533K 0.1% 321
2020
Q4 		$254K Sell
3,031
-8,673
-74% -$524K 0.04% 512
2020
Q3 		$419K Buy
11,704
+1,610
+16% +$48.5K 0.07% 358
2020
Q2 		$244K Buy
+10,094
New +$237K 0.05% 463

Other funds holding DNLI

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Quantitative Systematic Strategies's DNLI Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of Denali Therapeutics (DNLI) in Q3 2021, closing a stake of 4,301 shares — an estimated $337K sold.

Quantitative Systematic Strategies first reported a position in DNLI in Q2 2020 and held it in 5 quarters. The position peaked at $628K in Q1 2021. 214 funds tracked by Wall St. Rank hold DNLI as of Q3 2021.

  • Quantitative Systematic Strategies reported no remaining Denali Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 4,301 Denali Therapeutics shares in Q3 2021, an estimated $337K.
  • Quantitative Systematic Strategies first reported a position in Denali Therapeutics in Q2 2020 and held it in 5 quarters.
  • Quantitative Systematic Strategies's Denali Therapeutics position peaked at $628K in Q1 2021.
  • 214 funds tracked by Wall St. Rank held Denali Therapeutics as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.